Immediate Impact
12 standout
Citing Papers
Potentials and future perspectives of multi-target drugs in cancer treatment: the next generation anti-cancer agents
2024 Standout
Clinical and translational attributes of immune-related adverse events
2024 Standout
Works of Javier Sabater being referenced
Sequential Treatment Approaches in the Management of BRAF Wild-Type Advanced Melanoma: A Cost–Effectiveness Analysis
2018
Can We Accurately Predict Cost Effectiveness Without Access to Overall Survival Data? The Case Study of Nivolumab in Combination with Ipilimumab for the Treatment of Patients with Advanced Melanoma in England
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Javier Sabater | 61 | 39 | 10 | 13 | 22 | 101 | |
| Amy L. Pasternak | 37 | 16 | 5 | 25 | 26 | 198 | |
| Seungjean Chai | 55 | 33 | 4 | 17 | 13 | 115 | |
| Rositsa Koleva‐Kolarova | 79 | 66 | 8 | 9 | 25 | 203 | |
| Bruce Colwell | 138 | 30 | 7 | 20 | 16 | 170 | |
| Miriam O’Connor | 42 | 23 | 3 | 9 | 18 | 106 | |
| Aneta Suder | 51 | 26 | 3 | 8 | 13 | 112 | |
| Natalie Hoog-Labouret | 66 | 18 | 8 | 16 | 23 | 165 | |
| Pankaj Mistry | 83 | 13 | 16 | 21 | 18 | 170 | |
| Kian Meng Chang | 26 | 5 | 17 | 14 | 27 | 185 | |
| Ryan Ramaekers | 24 | 23 | 1 | 9 | 14 | 93 |
All Works
Login with ORCID to disown or claim papers
Loading papers...